Innovative CNS Therapies Noema Pharma specializes in developing groundbreaking therapies for central nervous system disorders, positioning it as a key player in the expanding neuropharmaceutical market with high unmet needs and strong growth potential.
Recent Funding Boost The company has secured significant financial investment, including a $147 million Series B funding round, indicating strong investor confidence and ample resources for ongoing research, development, and clinical trial activities.
Leadership Expansion Strategic appointments of senior executives including a new CEO, Chief Medical Officer, and VP of R&D demonstrate a focused effort to accelerate product development and move closer to commercialization, offering sales opportunities in research and clinical support services.
Growing Market Focus Targeting orphan CNS conditions that involve disabling symptoms, Noema Pharma operates in a niche yet high-demand segment, creating potential for specialized biotech and medical device collaborations, as well as clinical partnership opportunities.
Geographic and Industry Positioning Based in Basel with a focus on innovative neurotherapies, Noema Pharma's international presence and growth align well with partnerships in the biotech and pharmaceutical sectors seeking to expand in neuroscience treatment markets.
$1M$10M
$1B$10B
$1B$10B
$100M$250M
$10M$25M
$1B$10BNoema Pharma uses 8 technology products and services including Open Graph, JSON-LD, Priority Hints, and more. Explore Noema Pharma's tech stack below.
| Noema Pharma Email Formats | Percentage |
| FLast@noemapharma.com | 81% |
| First.Last@noemapharma.com | 8% |
| FirstLast@noemapharma.com | 7% |
| First-Last@noemapharma.com | 4% |
Biotechnology ResearchBasel-stadt, Switzerland11-50 Employees
Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies.
Company Overview
Media & News
Funding & FinancialsNoema Pharma has raised a total of $147M of funding over 3 rounds. Their latest funding round was raised on Dec 11, 2024 in the amount of $147M.
Noema Pharma's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsNoema Pharma has raised a total of $147M of funding over 3 rounds. Their latest funding round was raised on Dec 11, 2024 in the amount of $147M.
Noema Pharma's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com